Zobrazeno 1 - 4
of 4
pro vyhledávání: '"K A Oevrehus"'
Autor:
K T Madsen, B L Noergaard, K A Oevrehus, E Parner, J M Jensen, E L Grove, T A Fairbairn, K Nieman, M Patel, C Rogers, H Mickley, A Rohold, H E Boetker, J Leipsic, N P R Sand
Publikováno v:
European Heart Journal. 43
Introduction The short-term safety of using coronary CT angiography (CTA) derived fractional flow reserve (FFRCT) to guide downstream testing after CTA is well documented. Whether the prognostic information provided by FFRCT can be extended to sustai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::719819d10afc71c95d33e45a393b6992
https://doi.org/10.1093/eurheartj/ehac544.202
https://doi.org/10.1093/eurheartj/ehac544.202
Autor:
K T Madsen, B L Noergaard, K A Oevrehus, E Parner, J M Jensen, E L Grove, T A Fairbairn, K Nieman, M Patel, C Rogers, H Mickley, A Rohold, H E Boetker, J Leipsic, N P R Sand
Publikováno v:
European Heart Journal. 43
Introduction Major randomized trials of patients with stable chest pain (CP) demonstrated no prognostic benefits of coronary revascularization over optimal medical treatment (OMT). However, in a recent large-scale study, completeness of revasculariza
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2357c1a123319ee6831998d4e185601
https://doi.org/10.1093/eurheartj/ehac544.201
https://doi.org/10.1093/eurheartj/ehac544.201
Autor:
S Hasific, K A Oevrehus, J S Lindholt, A Mejldal, D Dey, S Auscher, J Lambrechtsen, S Hosbond, D Alan, G Urbonaviciene, S Becker, L M Rasmussen, A P Diederichsen
Publikováno v:
European Heart Journal. 43
Background Coronary artery calcification (CAC) and especially progression in CAC is a strong predictor of acute myocardial infarction (AMI) and cardiovascular mortality [1]. Observational studies suggest a protective role of vitamin K2 in the develop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68cda6075f617e5fd7f43989ea834fff
https://doi.org/10.1093/eurheartj/ehac544.1227
https://doi.org/10.1093/eurheartj/ehac544.1227
Autor:
Martin Busk, Jess Lambrechtsen, G Urbonaviciene, Kenneth Bruun Pedersen, N. P. Roennow Sand, Oke Gerke, J. S. Lindholt, Jens Steen Nielsen, Louise C. Pyndt Raun Diederichsen, Lars Melholt Rasmussen, A.C. Diederichsen, Hans Mickley, Selma Hasific, K. A. Oevrehus, Jesper Hallas
Publikováno v:
European Heart Journal. 40
Background Vitamin K antagonists (VKA) are the most frequently prescribed oral anticoagulants worldwide although new oral anticoagulants (NOAC) have become an important alternative. VKA inhibits Vitamin K1 necessary to produce coagulation factors but
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d568ad1d0c50a6c99c57748a8fe7dc1
https://doi.org/10.1093/eurheartj/ehz747.0115
https://doi.org/10.1093/eurheartj/ehz747.0115